PRENTISS CHRISTOPHER B (Chief Accounting Officer) sold 1.6% of their position (2.42K shares) of ADAMAS PHARMACEUTICALS INC on the open market
Open‑market sale worth $13.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/23/2021ACC: 0001209191-21-022631
Officer· Chief Accounting Officer
Since Dec 2018
-2.42K
Net shares
Net seller
$13.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.42K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.42K
Price / share
$5.48
Trade value
$13.27K
% of position
1.6%
3/22/2021
147.44K→145.02K
Total
Net shares
−2.42K
Net value
-$13.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/22/2021 | S · Sale | −2.42K | $5.48 | $13.27K | 1.6% | 147.44K | 145.02K |
| Total | −2.42K | -$13.27K | ||||||
Derivative Transactions0
No derivative transactions reported